RXO Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

RXO heeft een totaal eigen vermogen van $1.7B en een totale schuld van $362.0M, wat de schuld-eigenvermogensverhouding op 21.9% brengt. De totale activa en totale passiva bedragen respectievelijk $3.4B en $1.7B. De EBIT RXO is $39.0M waardoor de rentedekking 1.3 is. Het heeft contanten en kortetermijnbeleggingen van $55.0M.

Belangrijke informatie

21.9%

Verhouding schuld/eigen vermogen

US$362.00m

Schuld

Rente dekkingsratio	1.3x
Contant	US$55.00m
Aandelen	US$1.65b
Totaal verplichtingen	US$1.74b
Totaal activa	US$3.39b

Recente financiële gezondheidsupdates

Does RXO (NYSE:RXO) Have A Healthy Balance Sheet?

Nov 10

Here's Why RXO (NYSE:RXO) Has A Meaningful Debt Burden

Feb 08

Recent updates

RXO, Inc.'s (NYSE:RXO) Popularity With Investors Is Under Threat From Overpricing

Jan 04

RXO Inc.'s Road To Recovery, Navigating Through Economic Turns

Dec 20

Some Investors May Be Worried About RXO's (NYSE:RXO) Returns On Capital

Nov 30

RXO: Steering Through The Freight Frenzy

Sep 13

RXO: Innovative Technologies Supporting Transportation, And Cheap

Jun 13

Non-GAAP EPS of $0.28 beats by $0.05, revenue of $1.1B misses by $80M

Feb 07

RXO Inc: Near-Term Headwinds Could Provide Better Entry Point

Jan 20

RXO Inc. - A (Bullish) Early Look

Nov 06

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $1.3B ) RXO } overtreffen de korte termijn passiva ( $947.0M ).

Langlopende schulden: De kortetermijnactiva RXO ( $1.3B ) overtreffen de langetermijnschulden ( $793.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 18.6% ) RXO wordt als voldoende beschouwd.

Schuld verminderen: Er zijn onvoldoende gegevens om te bepalen of de schuld/eigen vermogen-ratio van RXO de afgelopen 5 jaar is gedaald.

Schuldendekking: De schuld van RXO wordt niet goed gedekt door de operationele kasstroom ( 3.9% ).

Rentedekking: De rentebetalingen van RXO op haar schulden worden niet goed gedekt door EBIT ( 1.3 x dekking).

RXO Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does RXO (NYSE:RXO) Have A Healthy Balance Sheet?

Here's Why RXO (NYSE:RXO) Has A Meaningful Debt Burden

Recent updates

Does RXO (NYSE:RXO) Have A Healthy Balance Sheet?

Third quarter 2024 earnings: EPS misses analyst expectations

RXO Emerges Stronger With The Freight Recession In The Rearview

RXO, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Chief Financial Officer exercised options and sold US$384k worth of stock

RXO, Inc. (NYSE:RXO) completed the acquisition of Coyote Logistics, LLC from United Parcel Service of America, Inc., UPS Corporate Finance S.ár.l and UPS SCS (UK) Ltd.

RXO, Inc. has filed a Follow-on Equity Offering in the amount of $350 million.

RXO, Inc. has completed a Follow-on Equity Offering in the amount of $500.00002 million.

RXO, Inc. has filed a Follow-on Equity Offering in the amount of $350 million.

RXO Launches Prepay Fuel Option for Carriers

New minor risk - Shareholder dilution

RXO, Inc. announced that it expects to receive $549.937418 million in funding from MFN Partners Management, LP

RXO, Inc. announced that it expects to receive $549.937418 million in funding from MFN Partners Management, LP

Second quarter 2024 earnings: EPS misses analyst expectations

Price target increased by 9.6% to US$26.23

Price target increased by 8.4% to US$23.92

Price target increased by 7.3% to US$22.69

RXO, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Price target increased by 7.3% to US$21.38

RXO, Inc. (NYSE:RXO) entered into a definitive agreement to acquire Coyote Logistics, LLC from United Parcel Service, Inc. (NYSE:UPS) for $1 billion.

RXO, Inc. (NYSE:RXO) entered into a definitive agreement to acquire Coyote Logistics, LLC from United Parcel Service, Inc. (NYSE:UPS) for $1 billion.

Here's What's Concerning About RXO's (NYSE:RXO) Returns On Capital

RXO, Inc.: Upgrade To Buy On Positive Volume And Pricing Outlook

CEO & Director exercised options and sold US$411k worth of stock

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Insufficient Growth At RXO, Inc. (NYSE:RXO) Hampers Share Price

RXO, Inc. to Report Q1, 2024 Results on May 02, 2024

Consensus EPS estimates increase by 104%

Consensus EPS estimates fall by 77%

Consensus EPS estimates increase by 40%

CEO & Director exercised options and sold US$771k worth of stock

Full year 2023 earnings: EPS exceeds analyst expectations

Here's Why RXO (NYSE:RXO) Has A Meaningful Debt Burden

RXO Launches AI-Powered Truck Check-In Technology for Warehouses and Distribution Centers

RXO, Inc. to Report Q4, 2023 Results on Feb 08, 2024

Chairman exercised options and sold US$465k worth of stock

RXO, Inc.'s (NYSE:RXO) Popularity With Investors Is Under Threat From Overpricing

RXO Inc.'s Road To Recovery, Navigating Through Economic Turns

Some Investors May Be Worried About RXO's (NYSE:RXO) Returns On Capital

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 11%

RXO, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Chief Financial Officer exercised options and sold US$273k worth of stock

RXO: Steering Through The Freight Frenzy

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

RXO, Inc. to Report Q2, 2023 Results on Aug 02, 2023

RXO, Inc. to Report Q2, 2023 Results on Aug 02, 2023

RXO, Inc.(NYSE:RXO) dropped from FTSE All-World Index (USD)

RXO: Innovative Technologies Supporting Transportation, And Cheap

CEO & Director exercised options and sold US$379k worth of stock

RXO, Inc. (NYSE:RXO) announces an Equity Buyback for $125 million worth of its shares.

First quarter 2023 earnings released

Full year 2022 earnings: EPS and revenues miss analyst expectations

Non-GAAP EPS of $0.28 beats by $0.05, revenue of $1.1B misses by $80M

Investor sentiment improves as stock rises 16%

RXO, Inc. Announces Launch of RXO Extra, the Expanded Carrier Rewards and Online Marketplace

RXO Inc: Near-Term Headwinds Could Provide Better Entry Point

RXO, Inc. to Report Q4, 2022 Results on Feb 07, 2023

Consensus forecasts updated

CEO & Director exercised options and sold US$62k worth of stock

Third quarter 2022 earnings released

Now 20% undervalued

High number of new and inexperienced directors

RXO Inc. - A (Bullish) Early Look

RXO, Inc. Announces Board Changes

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven